Published in Hepatitis Weekly, October 26th, 1998
The emergence of hepatitis C virus (HCV) variants with altered peptide ligands as T-cell receptor (TCR) antagonists accompanied by a limited TCR repertoire may provide a mechanism for HCV chronicity," S.L. Tsai and colleagues wrote ("Hepatitis C Virus Variants Circumventing Cytotoxic T Lymphocyte Activity as a Mechanism of Chronicity," Gastroenterology, October 1998;115(4):954-965).
High rate of chronicity after acute HCV infection cannot be explained in the presence of a multispecific cytotoxic T...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.